A clinical study that began in a research unit in Gqeberha (PE), Eastern Cape, has transformed global treatment of ...

Haryana minister Aarti Singh Rao has urged citizens, corporate organisations and voluntary groups to enrol as 'Nikshay Mitras' and support tuberculosis patients by providing nutritional and ...

South Africa has once again made medical history: BEAT Tuberculosis’s clinical study set a global standard for TB care and was published in the New England Journal of Medicine (NEJM), the world’s ...

If approved, upadacitinib is expected to be the first systemic medication for patients with non-segmental vitiligo, addressing important treatment needs ...

Much of what is known about Ebola virus disease comes from outbreaks of Orthoebolavirus zairense and Orthoebolavirus sudanense. Although these provide important lessons for the current response, ...

South Africa’s rollout of the twice-yearly HIV prevention injection lenacapavir could transform the fight against HIV, but ...

To accelerate India's efforts to combat anaemia, the centre on Monday launched revised guidelines, which for the first-time ...

The roll-out of South Africa's six-monthly HIV prevention medication lenacapavir (LEN) has to consider our other epidemic: TB. The arrival of the nearly foolproof six-monthly HIV prevention shot, ...

A research team led by Professor Kim Kwan-chang of the Department of Thoracic and Cardiovascular Surgery, Professor Kang ...

From TB, to ear infections, growth in children, excessive screen time, wheezing and asthma in little lungs, to blood tests ...

Discover how AI is transforming healthcare while keeping human clinicians at the centre of care, ensuring safer, more personalised and patient-focused treatment.

AbbVie (NYSE: ABBV) today announced the U.S. Food and Drug Administration (FDA) has approved SKYRIZI® (risankizumab-rzaa) for the treatment of children six years of age and older with ...